Weekly roundup: Launches, leadership moves & your essential Spring biotech event guide
Biocomposites launches SYNICEM™ spacers in Canada
Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, has launched its SYNICEM™ hip, knee and shoulder preformed spacers in Canada. It follows the launch of the same products in the US last October. Biocomposites, which is based in Keele, Staffordshire, England, was earlier this month named as one of the UK’s 100 fastest growing technology companies by The Sunday Times. See here for The Sunday Times’ 100 Tech 2026 list: https://www.thetimes.com/sunday-times-100-tech
Poolbeg Pharma plc – Peer-reviewed POLB 001 LPS challenge trial paper published in Frontiers in Immunology
Poolbeg Pharma, a clinical-stage biopharmaceutical company with a core focus on transforming the cancer immunotherapy field, announced the publication of a peer-reviewed paper from the POLB 001 LPS human challenge trial in Frontiers in Immunology. The paper details how POLB 001 significantly reduced key inflammatory biomarkers and immune cell recruitment following LPS challenge in healthy volunteers, that it was safe and well tolerated across all dose levels, and that it potently inhibits p38 MAPK driven cytokine responses. Publication endorses significant potential of POLB 001 with the interim data anticipated from the TOPICAL trial this summer.
TECregen appoints drug development veteran Dr. Klaas P. Zuideveld as Chief Executive Officer to lead thymus regeneration platform into clinical development
TECregen, a biotechnology company pioneering thymus rejuvenation, announced the appointment of Dr. Klaas P. Zuideveld, Ph.D., as CEO. Dr. Zuideveld will lead TECregen’s strategy and execution as the company advances its thymopoietic biologics designed to rejuvenate thymic epithelial cells (TECs), restore immune function, and strengthen immune resilience. The appointment follows the Basel-based biotech’s recent CHF 10 million Seed Financing.
ViCentra appoints diabetes commercialisation leader Reman McDonagh as Vice President, Global Marketing
ViCentra, a European medical device company commercialising the Kaleido insulin patch pump system, announced that Reman McDonagh, PhD, has joined the Company as Vice President, Global Marketing. McDonagh’s appointment further strengthens ViCentra’s leadership team as the company scales commercial execution across Europe and advances preparations for its next-generation Kaleido system, including EU and U.S. launches.
Hansa Biopharma to host 2025 year-end report conference call
Hansa Biopharma will publish its year-end report for January – December 2025 on Wednesday 11 February, 2026. Interested parties may join the Company’s quarterly conference call on the same date at 14:00 CET / 8:00 AM EST. During the call, management will review the Company’s year-end financial results and provide a business and pipeline update. The presentation will be held in English and is available at this link.
Four additional sites open for recruitment in Oncoinvent’s Phase 2 trial
Oncoinvent, a clinical stage, radiopharmaceutical company developing innovative treatments for solid cancers, announces that the first patient has been enrolled at one of the newly activated sites in its Phase 2 study of Radspherin® in patients with peritoneal carcinomatosis from ovarian cancer.
🏆 Industry awards
Huge congratulations to Ruth McKernan on being honoured with the BIA Lifetime Achievement Award at last night’s BIA Gala Dinner. This recognition is so well deserved and reflects her extraordinary contributions to the UK life sciences sector over many years and her dedication to finding a solution for patients living with dementia.
🔥Hot topic
Spring is the season for life sciences and healthcare innovation – now is the time to map out your conference calendar! We’ve rounded up the must-attend events across Europe, where biotech leaders, investors, and innovators will gather to shape the future of healthcare.
Plus, don’t miss out on exclusive discounts, early-bird savings, and special rates secured through Optimum. Read this week’s hot topic below to find out more.
👥 Industry events
This week, Optimum’s CEO Mary Clark, gave attendees of Uppsala International Business Week 2026 top tips on how to attract international investment!
Don’t worry if you missed it because you can now watch Mary in action here: Uppsala International Business Week 2026: UIBW 2026
Last call to pitch @ Anglonordic Life Sciences Conference – apply by 31st January
The 22nd Annual Anglonordic Life Science Conference is taking place at County Hall, London, UK on Thursday 23rd April.
Pitch presentation slots are £850 +VAT and includes:
- 10-minute presentation (including Q&A)
- 1 delegate pass, for The Reception and Anglonordic Conference
- Pre-event online pitch evaluation and support
- Social media promotion
- Enhanced profile and early access to the 1:1 partnering system
- Company profile featured in the conference program with speaker photo
🧩Sector moves
Keep up to date with the latest industry moves here.
That’s all folks! To stay in the know – subscribe to Optimum’s weekly wrap-up today!
